Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

New treatment could save 1,000

Annabel Ferriman
Tuesday 01 April 1997 23:02 BST
Comments

A new method of delivering anti-cancer drugs to patients after bowel cancer surgery might prevent about 1,000 deaths a year in the UK, the Imperial Cancer Research Fund says today.

The new approach, of feeding drugs directly into the liver, through a tube inserted during surgery (portal vein infusion), means that more of the drug reaches this gland than when drugs are delivered in the normal way - by mouth or injecting them into the bloodstream. Reaching the liver is essential because it is the most common site for recurrence of bowel cancer, which kills 18,000 people a year in the UK and is the second leading cause of cancer deaths.

Researchers at the charity's Cancer Studies Unit in Oxford carried out a review of data on 4,000 patients in 10 studies world-wide and found that portal vein infusion appeared to reduce deaths by 5 per cent. Professor Richard Peto, the unit's head, said: "PVI is an unusually convenient cancer treatment. It's given for just one week after surgery and has few major side-effects."

Portal Vein Chemotherapy for Colorectal Cancer, Journal of the National Cancer Institute, 2 April 1997. Annabel Ferriman

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in